VISTAGEN THERAPEUTICS, INC. Payments of Merger Related Costs, Financing Activities
VISTAGEN THERAPEUTICS, INC. (VTGN) reported Payments of Merger Related Costs, Financing Activities of $161.90 thousand for the 3-month period ending 2021-06-30, per its 10-Q filed 2021-08-12.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfMergerRelatedCostsFinancingActivities · last filed 2021-08-12
- VISTAGEN THERAPEUTICS, INC. payments of merger related costs, financing activities for the quarter ending 2021-06-30 was $161.90K, a 450.68% increase year-over-year.
- VISTAGEN THERAPEUTICS, INC. payments of merger related costs, financing activities for the quarter ending 2020-06-30 was $29.40K.
| Period end | Payments of Merger Related Costs, Financing Activities 3 month |
|---|---|
| 2021-06-30 | $161.90K 10-Q · filed 2021-08-12 |
| 2020-06-30 | $29.40K 10-Q · filed 2021-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |